Lilly Falls on Oral Obesity Pill as FDA Decision Looms
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Find starter accounts offering high interest and learn how to compare introductory yields and account features quickly.
25,613 articlesEli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Jim Cramer says the on-the-ground reality for NVIDIA looks sturdier than feared, a view that could lift NVIDIA stock ...
When a CEO sells a sizable stake, investors take notice. This deep dive looks at what sentinelone stock sell after si...
When Nvidia shares stumble, savvy investors look for high-potential AI names that can keep delivering. Here are two s...
Royal Caribbean enters 2026 with strong demand, but fuel cost headwinds and a heavy capex slate threaten margins, rem...
JPMorgan has begun a pilot that compares junior bankers' self-reported hours to computer activity, including keystrok...
Insmed disclosed that Japan now hosts more MAC lung disease patients than the United States, a development that could...
A major broker cuts Alibaba's target to $170 after a sharp drop in Q3 profits, driven by heavy AI investment. The clo...
Bitcoin dropped below the $67,000 level as U.S. Treasury yields climbed toward yearly highs, igniting a risk-off shak...
This in-depth analysis breaks down Celanese’s 2025 earnings trajectory, highlighting drivers, margins, and cash flow....
Los Angeles-based luxury real estate brokerage Resident is expanding into Napa Valley, signaling a broader push into ...
Hyped up rare-earth plays attract attention, but many stumble before they mine. This guide breaks down how to assess ...